Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Clinical trial NCT07042919 · RECRUITING

Trial details

NCT number: NCT07042919
Sponsor: Devalingam Mahalingam
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma Cirrhosis Stage III Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8

Start date: 2026-03-30
Primary completion: 2029-03-04
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.